As the world reckoned with COVID-19's most visible devastations, the kidneys were quietly absorbing damage that would only reveal itself months or years later. Research emerging from Göttingen and beyond has established that the kidneys are not merely collateral casualties of severe infection — they are early witnesses to it, their distress legible in a simple urine test long before a patient's condition visibly deteriorates. For the millions who survived COVID-19 without obvious acute crisis, this science carries a sobering message: the absence of dramatic illness does not guarantee the absen
COVID-19 Poses Long-Term Kidney Risks; Early Urinary Changes Signal Severe Disease
COVID-19 patients with kidney involvement face dramatically increased mortality risk and potential progression to chronic kidney disease requiring dialysis.
Kidney values are a seismograph for the course of COVID-19
Mark
So a simple urine test can tell us who's going to get sicker from COVID?
Mimi
Not perfectly, but yes—early changes in the urine correlate with worse disease. The study tracked 145 patients and found that kidney markers predicted ICU admission or death. It's one of the clearest early warning signs we have.
Luke
How reliable is this prediction? Was it tested on a separate group of patients, or just the same cohort?
Mimi
The source describes it as a predictive cohort, but doesn't specify whether the prediction was validated on a different population. That's an important distinction.
Mark
And the mortality difference—tenfold—that's from one Chinese study?
Mimi
Yes. Patients with kidney involvement had an 11.2 percent mortality rate versus 1.25 percent without it. That's a dramatic difference, but it's one study.
Luke
Were those patients comparable in age, severity at admission, other risk factors? The source doesn't say.
Mimi
It doesn't. We know the numbers, but not the full context around them.
Mark
What about people who recover from acute kidney injury? Are they really at risk for chronic kidney disease?
Mimi
Over half of them develop chronic kidney disease, according to data Gross cites. And even among those who initially recover, 14.7 percent have relapses and persistent problems.
Luke
Again, those are figures from other studies—Kellum's work, Chinese research. The source doesn't tell us how many COVID-19 patients we're actually talking about in absolute terms.
Mimi
True. We know the proportions, but not the total number of people affected.
Mark
So what should someone who had COVID actually do?
Mimi
Get your kidney function checked regularly—GFR and albumin levels—especially if you were hospitalized or had severe disease. Early treatment can make a real difference in slowing decline.
Luke
And if you had mild COVID with no kidney symptoms?
Mimi
The expert says to be cautious and get checked anyway, because viral tissue damage has been detected in organs even without obvious acute injury. But the source doesn't quantify how common that is.
Il Polso
- A tenfold gap in mortality separates COVID-19 patients with kidney involvement from those without it, making early kidney damage one of the disease's most consequential and underappreciated risk signals.
- Simple urine test strips can detect albumin and blood cell abnormalities early in infection, giving clinicians a rare window to anticipate — and potentially redirect — a patient's deteriorating trajectory.
- More than half of COVID-19 patients who suffer acute kidney injury go on to develop chronic kidney disease, and nearly one in seven who initially recover later relapse into persistent dysfunction.
- New therapies like SGLT-2 inhibitors can delay dialysis by years or even decades, but only if kidney damage is caught and treated before the silent progression reaches an irreversible threshold.
- Kidney disease produces no symptoms until its advanced stages, meaning millions of COVID-19 survivors may be carrying undetected damage that routine post-recovery screening could still intercept.
As the world reckoned with COVID-19's most visible devastations, the kidneys were quietly absorbing damage that would only reveal itself months or years later. Research emerging from Göttingen and beyond has established that the kidneys are not merely collateral casualties of severe infection — they are early witnesses to it, their distress legible in a simple urine test long before a patient's condition visibly deteriorates. For the millions who survived COVID-19 without obvious acute crisis, this science carries a sobering message: the absence of dramatic illness does not guarantee the absence of lasting harm.
When COVID-19 infects the body, the kidneys are among the first organs to register the assault — and that early distress, it turns out, contains a diagnostic signal. Professor Oliver Gross and his team at Göttingen University Medical Center tracked hundreds of COVID-19 patients and found that urinary abnormalities detected in the early days of infection could predict which patients would face the most severe outcomes, including intensive care and death. Combining urine and blood kidney markers into a predictive system, Gross described kidney values as a "seismograph" for the disease's course. German clinical guidelines now recommend routine urinalysis for all hospitalized COVID-19 patients.
The mortality stakes are stark. A Chinese study found that COVID-19 patients with kidney involvement died at a rate of 11.2 percent — compared to just 1.25 percent among those without it. Beyond acute kidney injury, earlier and subtler signs — protein in the urine, low blood protein, clotting deficiencies — have also emerged as independent predictors of death, expanding the window during which intervention might matter.
The long-term picture is equally sobering. While acute kidney injury often resolves within days, a significant share of patients never regain full function. Research shows that over 40 percent of those with moderate to severe acute kidney injury experienced no recovery at all, and among those who initially improved, nearly 15 percent later relapsed. Data from China suggest that more than half of COVID-19 patients who develop acute kidney injury will eventually progress to chronic kidney disease.
Gross stresses that early, aggressive treatment — particularly with SGLT-2 inhibitors — can delay or even prevent the need for dialysis for years. But the concern reaches beyond those who suffered obvious kidney failure: molecular evidence of SARS-CoV-2 damage has been found in multiple organs, raising the possibility of long-term harm in patients who never appeared critically ill.
His recommendation is direct: kidney function must become a standard pillar of COVID-19 aftercare, alongside assessments of the lungs, heart, and nervous system. Because kidney disease advances silently, survivors and their general practitioners need to monitor glomerular filtration rates and albumin levels routinely — the same vigilance applied to patients with diabetes or hypertension. The tools to intervene exist; the challenge now is ensuring the window to use them does not quietly close.
The kidneys emerge early as a target organ in COVID-19 infection, and this vulnerability carries a hidden advantage: the damage itself becomes a diagnostic signal. Researchers have discovered that changes in urine—detectable with simple test strips—can forecast which patients will face the most severe disease trajectories, including intensive care admission or death.
Professor Oliver Gross and his team at Göttingen University Medical Center screened 223 COVID-19 patients and tracked 145 of them as a predictive cohort. The finding was direct: early urinary abnormalities correlated with worse outcomes. When kidney markers from both urine and blood were combined into a predictive system, clinicians could anticipate how severely the disease would progress. "Kidney values are a seismograph for the course of COVID-19 disease," Gross explained at the 2021 ERA-EDTA Congress. The German S3 guideline now recommends that hospitalized COVID-19 patients receive urinalysis—repeated as needed—to measure albumin, blood cells, and white blood cells in the urine.
The stakes extend beyond prediction. Kidney involvement in COVID-19 patients dramatically worsens survival odds. A Chinese study found that patients showing signs of kidney damage faced mortality rates ten times higher than those without it: 1.25 percent of patients without kidney involvement died, compared to 11.2 percent of those with kidney involvement. Until recently, acute kidney injury was the only recognized independent predictor of death in COVID-19 cases. Now evidence shows that earlier signs—protein in the urine, low blood protein levels, deficiencies in clotting factors—also carry predictive weight.
The long-term picture is more troubling still. Acute kidney injury typically resolves within seven days, but acute kidney disease can take up to 90 days to recover. Many patients never recover at all. Research by Kellum and colleagues showed that 41.2 percent of patients with moderate to severe acute kidney injury experienced no recovery of kidney function. Among those who initially improved, 14.7 percent suffered relapses and persistent kidney dysfunction. One year after the acute injury, these patients faced significantly worse outcomes, including higher mortality rates and need for dialysis.
Data from China suggest that just over half of all COVID-19 patients who develop acute kidney injury will go on to develop chronic kidney disease. Gross emphasizes the importance of bringing these patients into specialized kidney care: early and aggressive treatment can slow or halt the decline in kidney function. New therapies, particularly SGLT-2 inhibitors, have proven effective in recent years at delaying or preventing the need for dialysis—sometimes for decades—if treatment begins promptly.
But the concern extends beyond those who suffered acute kidney failure. Patients with only mild early kidney dysfunction also warrant caution. Molecular evidence of SARS-CoV-2 tissue damage has been detected in multiple organs where the virus replicates, raising the possibility of long-term organ damage and post-COVID complications in people who never experienced obvious acute illness.
Gross's central recommendation is clear: kidney function must become a standard part of COVID-19 aftercare, alongside assessment of the lungs, heart, and nervous system. Because kidney disease produces no symptoms until advanced stages, COVID-19 survivors need to understand the risk. General practitioners should routinely check kidney values—glomerular filtration rate and albumin levels—in their recovering patients, just as they do for people with diabetes or high blood pressure. The window for intervention is narrow, but the tools now exist to make a difference.
Citazioni salienti
Kidney values are a seismograph for the course of COVID-19 disease— Professor Oliver Gross, Göttingen University Medical Center
The kidney must be at the center of COVID-19 aftercare, in addition to the lungs, the heart and the nervous system— Professor Oliver Gross
Vuoi la storia completa?
Leggi l'originale su News-Medical.net ↗
Health & Medicine